vs
RED RIVER BANCSHARES INC（RRBI）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是RED RIVER BANCSHARES INC的1.1倍（$35.5M vs $33.2M），RED RIVER BANCSHARES INC净利率更高（34.4% vs -304.2%，领先338.6%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 15.7%），RED RIVER BANCSHARES INC自由现金流更多（$42.2M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 12.4%）
Red River Bancshares Inc是一家美国地区性金融控股公司，通过旗下子公司红河银行开展业务，提供零售与商业银行服务，包含存款账户、个人及商业贷款、抵押贷款、财富管理等产品，主要服务路易斯安那州的本地社区及中小企业客户。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
RRBI vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $33.2M | $35.5M |
| 净利润 | $11.4M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 42.8% | -304.8% |
| 净利率 | 34.4% | -304.2% |
| 营收同比 | 15.7% | 681.7% |
| 净利润同比 | 22.7% | 39.6% |
| 每股收益（稀释后） | $1.72 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $33.2M | $35.5M | ||
| Q3 25 | $31.9M | $5.2M | ||
| Q2 25 | $30.5M | $19.2M | ||
| Q1 25 | $29.9M | $14.7M | ||
| Q4 24 | $28.7M | $4.5M | ||
| Q3 24 | $27.9M | $26.1M | ||
| Q2 24 | $26.9M | $14.4M | ||
| Q1 24 | $26.3M | $13.8M |
| Q4 25 | $11.4M | $-108.1M | ||
| Q3 25 | $10.8M | $-162.3M | ||
| Q2 25 | $10.2M | $-171.9M | ||
| Q1 25 | $10.4M | $-202.5M | ||
| Q4 24 | $9.3M | $-178.9M | ||
| Q3 24 | $8.8M | $-95.8M | ||
| Q2 24 | $8.0M | $-97.5M | ||
| Q1 24 | $8.2M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | 42.8% | -304.8% | ||
| Q3 25 | 41.9% | -3327.6% | ||
| Q2 25 | 41.7% | -916.8% | ||
| Q1 25 | 43.0% | -1297.9% | ||
| Q4 24 | 40.2% | -4042.4% | ||
| Q3 24 | 38.8% | -377.1% | ||
| Q2 24 | 36.8% | -697.4% | ||
| Q1 24 | 38.5% | -698.4% |
| Q4 25 | 34.4% | -304.2% | ||
| Q3 25 | 33.8% | -3135.3% | ||
| Q2 25 | 33.4% | -894.2% | ||
| Q1 25 | 34.6% | -1373.3% | ||
| Q4 24 | 32.4% | -3935.5% | ||
| Q3 24 | 31.4% | -367.5% | ||
| Q2 24 | 29.7% | -676.6% | ||
| Q1 24 | 31.1% | -662.4% |
| Q4 25 | $1.72 | $-0.17 | ||
| Q3 25 | $1.63 | $-0.36 | ||
| Q2 25 | $1.51 | $-0.41 | ||
| Q1 25 | $1.52 | $-0.50 | ||
| Q4 24 | $1.36 | $-0.56 | ||
| Q3 24 | $1.27 | $-0.34 | ||
| Q2 24 | $1.16 | $-0.40 | ||
| Q1 24 | $1.16 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $213.4M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $365.1M | $1.1B |
| 总资产 | $3.4B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $213.4M | $743.3M | ||
| Q3 25 | $161.1M | $659.8M | ||
| Q2 25 | $210.4M | $525.1M | ||
| Q1 25 | $252.2M | $500.5M | ||
| Q4 24 | $269.0M | $594.4M | ||
| Q3 24 | $232.6M | $427.6M | ||
| Q2 24 | $213.1M | $474.3M | ||
| Q1 24 | $229.8M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $365.1M | $1.1B | ||
| Q3 25 | $351.3M | $1.0B | ||
| Q2 25 | $335.4M | $919.1M | ||
| Q1 25 | $333.3M | $933.9M | ||
| Q4 24 | $319.7M | $1.0B | ||
| Q3 24 | $324.3M | $524.6M | ||
| Q2 24 | $307.0M | $584.4M | ||
| Q1 24 | $299.3M | $401.2M |
| Q4 25 | $3.4B | $1.5B | ||
| Q3 25 | $3.2B | $1.4B | ||
| Q2 25 | $3.2B | $1.3B | ||
| Q1 25 | $3.2B | $1.3B | ||
| Q4 24 | $3.1B | $1.4B | ||
| Q3 24 | $3.1B | $726.5M | ||
| Q2 24 | $3.0B | $775.9M | ||
| Q1 24 | $3.1B | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $44.8M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $42.2M | $-47.3M |
| 自由现金流率自由现金流/营收 | 127.2% | -133.1% |
| 资本支出强度资本支出/营收 | 7.8% | 3.5% |
| 现金转化率经营现金流/净利润 | 3.92× | — |
| 过去12个月自由现金流最近4个季度 | $75.2M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $44.8M | $-46.1M | ||
| Q3 25 | $16.5M | $-117.4M | ||
| Q2 25 | $3.8M | $-76.4M | ||
| Q1 25 | $13.9M | $-132.0M | ||
| Q4 24 | $38.3M | $-115.4M | ||
| Q3 24 | $17.4M | $-59.2M | ||
| Q2 24 | $2.4M | $-82.2M | ||
| Q1 24 | $14.4M | $-102.3M |
| Q4 25 | $42.2M | $-47.3M | ||
| Q3 25 | $15.8M | $-117.6M | ||
| Q2 25 | $3.5M | $-79.6M | ||
| Q1 25 | $13.7M | $-133.8M | ||
| Q4 24 | $33.4M | $-116.7M | ||
| Q3 24 | $17.0M | $-63.8M | ||
| Q2 24 | $1.4M | $-83.4M | ||
| Q1 24 | $13.4M | $-109.0M |
| Q4 25 | 127.2% | -133.1% | ||
| Q3 25 | 49.6% | -2272.5% | ||
| Q2 25 | 11.6% | -413.9% | ||
| Q1 25 | 45.7% | -907.4% | ||
| Q4 24 | 116.5% | -2567.7% | ||
| Q3 24 | 60.9% | -244.6% | ||
| Q2 24 | 5.4% | -578.5% | ||
| Q1 24 | 50.8% | -789.9% |
| Q4 25 | 7.8% | 3.5% | ||
| Q3 25 | 2.1% | 4.7% | ||
| Q2 25 | 0.9% | 16.4% | ||
| Q1 25 | 0.9% | 12.4% | ||
| Q4 24 | 17.0% | 28.6% | ||
| Q3 24 | 1.4% | 17.5% | ||
| Q2 24 | 3.6% | 8.2% | ||
| Q1 24 | 4.0% | 48.2% |
| Q4 25 | 3.92× | — | ||
| Q3 25 | 1.53× | — | ||
| Q2 25 | 0.37× | — | ||
| Q1 25 | 1.34× | — | ||
| Q4 24 | 4.11× | — | ||
| Q3 24 | 1.99× | — | ||
| Q2 24 | 0.30× | — | ||
| Q1 24 | 1.76× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
